>
CLARIVATE logo

CLVT - CLARIVATE Share Price

$26.15 0.0  0.0%

Last Trade - 16/04/21

Sector
Industrials
Size
Large Cap
Market Cap £11.50bn
Enterprise Value £13.83bn
Revenue £906.8m
Position in Universe 712th / 6850
Bullish
Bearish
Unlock CLVT Revenue
Momentum
Relative Strength (%)
1m -6.61%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -22.1%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2015 2016 2017 2018 2019 2020 2021E 2022E CAGR / Avg
0.000 0.000 917.6 968.5 974.3 1,254 1,803 1,930 +11.0%
+23.8
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the fiscal year ended 31 December 2020,CLARIVATE PLC revenues increased 29% to $1.25B. Net lossdecreased 50% to $106.3M. Revenues reflect Americas segmentincrease of 36% to $631.2M, Europe/ Middle East /Africasegment increase of 31% to $365.6M. Lower net loss reflectsOther operating income (expense), net increase from $4.8Mto $52.4M (income), Interest expense decrease of 29% to$111.9M (expense).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

CLVT Revenue Unlock CLVT Revenue

Net Income

CLVT Net Income Unlock CLVT Revenue

Normalised EPS

CLVT Normalised EPS Unlock CLVT Revenue

PE Ratio Range

CLVT PE Ratio Range Unlock CLVT Revenue

Dividend Yield Range

CLVT Dividend Yield Range Unlock CLVT Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2020 /  2021
CLVT EPS Forecasts Unlock CLVT Revenue
Profile Summary

Clarivate PLC, formerly Clarivate Analytics Plc, is an information services and analytics company serving the scientific research, intellectual property and life sciences end-markets. The Company provides structured information and analytics to facilitate the discovery, protection and commercialization of scientific research, innovations and brands. The Company offers its products in two sub categories: Science group and Intellectual Property (IP) Group. Its product portfolio includes brands such as Web of Science, Derwent Innovation, Cortellis, CompuMark and MarkMonitor. The Company offers its structured information and analytical solutions to corporations, government agencies, universities, law firms and other professional services organizations worldwide.

Directors
Last Annual December 31st, 2020
Last Interim December 31st, 2020
Incorporated January 7, 2019
Public Since October 29, 2018
No. of Shareholders: 41
No. of Employees: 8,445
Sector Industrials
Industry Professional & Commercial Services
Index
Exchange New York Stock Exchange
Shares in Issue 607,980,173
Free Float (0.0%)
Eligible for
ISAs
SIPPs
CLVT Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for CLVT
Upcoming Events for CLVT
Thursday 29th April, 2021
Q1 2021 CLARIVATE PLC Earnings Call
Thursday 29th April, 2021
Q1 2021 CLARIVATE PLC Earnings Release
Thursday 6th May, 2021
CLARIVATE PLC Annual Shareholders Meeting
Friday 7th May, 2021 Estimate
CLARIVATE PLC Annual Shareholders Meeting
Wednesday 28th July, 2021 Estimate
Q2 2021 CLARIVATE PLC Earnings Release
Frequently Asked Questions for CLARIVATE
What is the CLARIVATE share price?

As of 16/04/21, shares in CLARIVATE are trading at $26.15, giving the company a market capitalisation of £11.50bn. This share price information is delayed by 15 minutes.

How has the CLARIVATE share price performed this year?

Shares in CLARIVATE are currently trading at $26.15 and the price has moved by 15.91% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the CLARIVATE price has moved by -20.1% over the past year.

What are the analyst and broker recommendations for CLARIVATE?

Of the analysts with advisory recommendations for CLARIVATE, there are there are currently 4 "buy" , 0 "hold" and 0 "sell" recommendations. The overall consensus recommendation for CLARIVATE is Buy. You can view the full broker recommendation list by unlocking its StockReport.

When will CLARIVATE next release its financial results?

CLARIVATE is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-12-31
What is the CLARIVATE dividend yield?

CLARIVATE does not currently pay a dividend.

Does CLARIVATE pay a dividend?

CLARIVATE does not currently pay a dividend.

When does CLARIVATE next pay dividends?

CLARIVATE does not currently pay a dividend.

How do I buy CLARIVATE shares?

To buy shares in CLARIVATE you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of CLARIVATE?

Shares in CLARIVATE are currently trading at $26.15, giving the company a market capitalisation of £11.50bn.

Where are CLARIVATE shares listed? Where are CLARIVATE shares listed?

Here are the trading details for CLARIVATE:

Country of listing: United States
Exchange: NYQ
Ticker Symbol: CLVT
What kind of share is CLARIVATE?

Based on an overall assessment of its quality, value and momentum, CLARIVATE is currently classified as a Style Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a CLARIVATE share price forecast 2021?

Shares in CLARIVATE are currently priced at $26.15. At that level they are trading at 23.48% discount to the analyst consensus target price of 0.00.

Analysts covering CLARIVATE currently have a consensus Earnings Per Share (EPS) forecast of 0.749 for the next financial year.

How can I tell whether the CLARIVATE share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like CLARIVATE. Over the past six months, the relative strength of its shares against the market has been -29.94%. At the current price of $26.15, shares in CLARIVATE are trading at -6.3% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the CLARIVATE PE Ratio?

We were not able to find PE ratio data for CLARIVATE.

Who are the key directors of CLARIVATE?

CLARIVATE's management team is headed by:

Jerre Stead - CHM
Kosty Gilis - IND
Balakrishnan Iyer - IND
Nicholas Macksey - IND
Anthony Munk - LED
Mukhtar Ahmed - CEX
Richard Hanks - CFO
Stephen Hartman - GCN
Jeffrey Roy - CEX
Usama Cortas - IND
Julie Wilson - CHO
Who are the major shareholders of CLARIVATE?

Here are the top five shareholders of CLARIVATE based on the size of their shareholding:

Leonard Green & Partners, L.P. Private Equity
Percentage owned: 19.19% (116.7m shares)
Onex Corporation Private Equity
Percentage owned: 11.75% (71.4m shares)
T. Rowe Price Associates, Inc. Investment Advisor
Percentage owned: 11.08% (67.3m shares)
Selige Co-Investor Pooling SCSp Corporation
Percentage owned: 6.27% (38.1m shares)
Select Equity Group, L.P. Investment Advisor/Hedge Fund
Percentage owned: 6.14% (37.3m shares)
Similar to CLVT
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.